共 94 条
[1]
Edlin BR(2015)Toward a more accurate estimate of the prevalence of hepatitis C in the United States Hepatology. 62 1353-1363
[2]
Eckhardt BJ(2013)Viral hepatitis and the global burden of disease: a need to regroup J Viral Hepat 20 600-601
[3]
Shu MA(2013)Chronic hepatitis C virus (HCV) disease burden and cost in the United States Hepatology. 57 2164-2170
[4]
Holmberg SD(2016)Endocarditis as a marker for new epidemics of injection drug use Am J Med Sci 352 609-614
[5]
Swan T(2013)The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease Top Antivir Med 21 15-19
[6]
Cooke GS(2015)Increases in hepatitis C virus infection related to injection drug use among persons aged </=30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012 MMWR Morb Mortal Wkly Rep 64 453-458
[7]
Lemoine M(2020)CDC recommendations for hepatitis C screening among adults — United States, 2020 MMWR Recomm Rep 69 1-17
[8]
Thursz M(2012)HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms Clin Infect Dis 55 S33-S42
[9]
Gore C(2012)Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965 MMWR Morb Mortal Wkly Rep 61 1-32
[10]
Swan T(2015)A comparison of routine, opt-out HIV screening with the expected yield from physician-directed HIV testing in the ED Am J Emerg Med 33 506-511